224 related articles for article (PubMed ID: 29538505)
1. Vimentin and Anti Vimentin Antibodies in Chagas' Disease.
Nascimento MS; Stolf AMS; Andrade Junior HF; Pandey RP; Umezawa ES
Arq Bras Cardiol; 2018 Apr; 110(4):348-353. PubMed ID: 29538505
[TBL] [Abstract][Full Text] [Related]
2. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
3. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
Yokoyama-Yasunaka JK; Piazza RM; Umezawa ES; Stolf AM
J Clin Lab Anal; 1998; 12(2):108-14. PubMed ID: 9524295
[TBL] [Abstract][Full Text] [Related]
5. Chagas' disease: humoral response to subcellular fraction of Trypanosoma cruzi in symptomatic and asymptomatic patients.
de Titto EH; Moreno M; Braun M; Segura EL
Trop Med Parasitol; 1987 Sep; 38(3):163-6. PubMed ID: 3124252
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein.
Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC
Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
8. Clinical Trypanosoma rangeli infection as a complication of Chagas' disease.
Guhl F; Hudson L; Marinkelle CJ; Jaramillo CA; Bridge D
Parasitology; 1987 Jun; 94 ( Pt 3)():475-84. PubMed ID: 2441341
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease.
Gironès N; Rodríguez CI; Basso B; Bellon JM; Resino S; Muñoz-Fernández MA; Gea S; Moretti E; Fresno M
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1039-43. PubMed ID: 11687436
[TBL] [Abstract][Full Text] [Related]
10. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
[TBL] [Abstract][Full Text] [Related]
11. [Observations on the use of TESA blot for the serological diagnosis of Chagas' disease].
Amato Neto V; De Marchi CR; Ferreira CS; Ferreira AW
Rev Soc Bras Med Trop; 2005; 38(6):534-5. PubMed ID: 16410935
[TBL] [Abstract][Full Text] [Related]
12. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to T. cruzi cytosol acidic antigens (FIV) in Chagas' disease recognize parasite cell surface and human heart epitopes.
Gea S; Gruppi A; Basso B; Menso E; Vottero-Cima E
J Clin Lab Immunol; 1990 Apr; 31(4):183-7. PubMed ID: 1726727
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal studies of the immune response of Colombian patients infected with Trypanosoma cruzi and T. rangeli.
Hudson L; Guhl F; de Sanchez N; Bridge D; Jaramillo CA; Young A
Parasitology; 1988 Jun; 96 ( Pt 3)():449-60. PubMed ID: 3136418
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
[TBL] [Abstract][Full Text] [Related]
16. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
[TBL] [Abstract][Full Text] [Related]
17. Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen.
Pérez-Fuentes R; Sánchez-Guillén MC; González-Alvarez C; Monteón VM; Reyes PA; Rosales-Encina JL
Am J Trop Med Hyg; 1998 Jun; 58(6):715-20. PubMed ID: 9660451
[TBL] [Abstract][Full Text] [Related]
18. Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies.
Gea S; Ordonez P; Cerban F; Iosa D; Chizzolini C; Vottero-Cima E
Am J Trop Med Hyg; 1993 Nov; 49(5):581-8. PubMed ID: 7504407
[TBL] [Abstract][Full Text] [Related]
19. Detection of Trypanosoma-decay accelerating factor antibodies in mice and humans infected with Trypanosoma cruzi.
Tambourgi DV; Cavinato RA; De Abreu CM; Peres BA; Kipnis TL
Am J Trop Med Hyg; 1995 Jun; 52(6):516-20. PubMed ID: 7611557
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease.
Affranchino JL; Ibañez CF; Luquetti AO; Rassi A; Reyes MB; Macina RA; Aslund L; Pettersson U; Frasch AC
Mol Biochem Parasitol; 1989 May; 34(3):221-8. PubMed ID: 2499788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
